Evidence map›Paper›PMID 12435635›Full record

ArticleGenes & development2002

The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Donato Tedesco, Jiri Lukas, Steven I Reed

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 261 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Donato TedescoDepartment of Molecular Biology, MB-7, The Scripps Research Institute, La Jolla, California 92037, USA.
Jiri Lukas
Steven I Reed
Scripps Research Institute · USDanish Cancer Society · DK

Funding

The role of Cyclin E in growth control and tumorogenesisR01CA078343 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI REED, STEVEN I · 1998 to 2019
$8.1M
The role of Cyclin E in growth control and tumorogenesisR56CA078343 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI REED, STEVEN I · 2008 to 2008
$348k
NCI NIH HHS CA78343NCI NIH HHS R01 CA078343NCI NIH HHS R56 CA078343
6 · The paper itself

Abstract

p130 is a tumor suppressor of the pocket protein family whose expression is posttranscriptionally regulated and largely G0 restricted. The mechanism of down-regulation of p130 expression in proliferating cells was investigated. Our results indicate that the decline of p130 expression as G0 cells reenter the cell cycle is due to a decrease in protein stability. The enhancement of p130 turnover in late G1 and S phase compared with G0 and early G1 phase was dependent on Cdk4/6-specific phosphorylation of p130 on Serine 672, and independent of Cdk2 activity. The activity of the ubiquitin ligase complex Skp1-Cul1/Cdc53-F-box protein Skp2 (SCF(Skp2)) and the proteasome were necessary for p130 degradation. In vitro, recombinant Skp2 was able to bind hyperphosphorylated but not dephosphorylated p130. Furthermore, in vitro polyubiquitination of p130 by SCF(Skp2) was specifically dependent on phosphorylation of p130 on Serine 672. Thus, like the Cdk inhibitor p27(Kip1), p130 turnover is regulated by Cdk-dependent G1 phosphorylation leading to ubiquitin-dependent proteolysis.

Indexed as

CDC2-CDC28 KinasesCell Cycle ProteinsProteinsProto-Oncogene ProteinsSaccharomyces cerevisiae ProteinsAdaptor Proteins, Signal TransducingCell CycleCells, CulturedCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Cyclin-Dependent KinasesCysteine EndopeptidasesFungal ProteinsHumansLigasesAdaptor Proteins, Signal TransducingCDC2-CDC28 KinasesCDK2 protein, humanCDK4 protein, humanCDK6 protein, humanCell Cycle ProteinsCKS1 protein, S cerevisiaeCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Cyclin-Dependent KinasesCysteine EndopeptidasesFungal ProteinsLigasesMultienzyme ComplexesPhosphoproteinsProteasome Endopeptidase ComplexProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsRBL2 protein, humanRetinoblastoma-Like Protein p130Saccharomyces cerevisiae ProteinsSerineUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID12435635
PMCPMC187481
OpenAlexW1971034699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.